View Fisher & Paykel Healthcare's Dividend History, Capital Management Policy and Dividend Reinvestment Plan.
If you require a dividend statement, please contact our Share Registrar using the contact details below:
LINK Market Services Limited Level 30, PwC Tower 15 Customs Street West Auckland 1010 PO Box 91976 Auckland 1142
Investor enquiries: +64 9 375 5998 Fax: +64 9 375 5990 enquiries@linkmarketservices.co.nz
LINK Market Services Limited Level 12, 680 George Street Sydney, NSW 2000 Locked Bag A14 Sydney South NSW 1235
Investor enquiries: +61 2 8280 7111 Fax: +61 2 9287 0303 registrars@linkmarketservices.com.au
In accordance with the company’s capital management policy, the company’s directors have approved a final dividend of 17.5 cents per share, an increase of 3% on the interim dividend last year. The interim dividend, carrying full New Zealand imputation credit, will be paid on 21 December 2022 with a record date of 9 December 2022.
Evidence and guidance for delivering Optiflow NHF, proven respiratory support for your patients.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks and full face NIV masks, with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Delivering warm, humidified carbon dioxide in laparoscopic and open surgery
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment